TNF-α in Uveitis: From Bench to Clinic

Area of Science:

• Ophthalmology
• Immunology
• Rheumatology

Background:

• Uveitis, an intraocular inflammation, often signals systemic autoimmune diseases.
• Tumor necrosis factor-alpha (TNF-α) is a key cytokine implicated in uveitis pathogenesis.
• Anti-TNF-α therapies show promise for managing uveitis.

Purpose of the Study:

• To review the role of TNF-α in uveitis immunopathogenesis.
• To summarize research progress on TNF-α in uveitis, from basic science to clinical application.
• To guide the development of TNF-α-based therapeutics for uveitis.

Main Methods:

• Literature review of experimental and clinical studies on TNF-α and uveitis.
• Analysis of the immunopathogenesis of TNF-α in intraocular inflammation.
• Synthesis of bench-to-bedside research findings.

Main Results:

• TNF-α plays a critical role in the inflammatory processes of uveitis.
• Evidence supports the clinical feasibility of anti-TNF-α agents for uveitis.
• A gap exists in comprehensive reviews of TNF-α's specific role and research in uveitis.

Conclusions:

• Understanding TNF-α's role is crucial for comprehending and treating uveitis.
• Further research into TNF-α mechanisms can optimize anti-TNF-α therapies.
• This review provides a foundation for advancing TNF-α-targeted uveitis treatments.